Primary care doctors in the UK are a “negligible” provider of commercial clinical trial activity and should be incentivised to give experimental therapies to patients.
The litany of failed experimental therapies for amyotrophic lateral sclerosis (ALS) added another verse today, after Apellis Pharma gave up on Sobi-partnered candidate peg
Cell and gene therapy specialist ElevateBio has taken the total fundraising since it launched five years ago to around $1.25 billion, with its latest $401 million round th
PTC Therapeutics has cued up no fewer than three clinical trial readouts this quarter that could lead to new regulatory filings – but the latest for vatiquinone in inherited nerve dis
The UK government has agreed to support the development of a rapid diagnostic from Oxford medtech firm Pictura Bio that could help manage infectious diseases amongst milit